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Proteasome-independent degradationa b s t r a c t
Free zinc is required for proper lipopolysaccharide (LPS)-stimulated signaling, but potential sites of
action in the pathway have not been deﬁned. In this work, we provide in vitro and ex vivo evidence
that zinc is not required for phosphorylation or ubiquitylation of IRAK1, a kinase functioning early
in the TLR4 pathway. However, degradation of ubiquitylated IRAK1 occurred via a zinc-dependent,
proteasome-independent pathway. These results provide evidence of a novel site of action for zinc
during TLR4-mediated inﬂammatory responses.
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Zinc is a micronutrient that is essential for a wide variety of bio-
chemical functions. In particular, zinc is essential for cell-mediated
innate immunity, affecting the function of neutrophils, natural
killer cells and macrophages. Many studies have documented the
adverse effects of zinc deﬁciency on the ability to mount an
immune response [1–6]. While certain requirements for zinc in
immune function undoubtedly relate to its roles as an enzymatic
cofactor [7,8] or a component of various structural motifs [9]
(e.g., zinc ﬁngers), more recent evidence points to additional roles
for zinc in regulating immune cell signaling [10–13]. Although free
ionic zinc in the cytoplasm is maintained at extremely low concen-
trations [14,15], the activation of certain immune cell types has
been shown to trigger the release of free zinc within cytoplasm
[10,11]. This transient pool of zinc, sometimes referred to as a
‘‘zinc wave’’, has been observed in response to a number
of stimuli, including FceRI activation in mast cells [10] and TLR1-,TLR2-, TLR4- and TNF-a activation in monocytes [11]. The levels
of intracellular zinc transiently increases, usually reaching a peak
a few minutes after induction by extracellular stimuli [11,16].
Although the effects of the transient zinc wave remain poorly
understood, it is possible that transient ﬂuxes in cytosolic zinc con-
centrations may serve as a type of a second messenger to modulate
signaling pathways elicited during early phases of the innate
immune response [12,16].
Evidence exists that zinc may be required for signal transduc-
tion events downstream of TLR recognition. TLR1, 2, and 4 recog-
nize pathogen associated molecular patterns of bacterial
components, such as triacyl lipoprotein, lipoprotein, and lipopoly-
saccharride (LPS) respectively [17]. Recognition of these extracellu-
lar ligands by their cognate receptors initiates an intracellular
signaling cascade resulting in the elevated transcription of many
genes that encode a range of proinﬂammatory mediators. Numer-
ous studies have shown that zinc plays a critical role in these path-
ways; however, the underlying molecular mechanisms are
unknown. For example, chelation of intracellular zinc in primary
monocytes or cultured macrophage cell lines blocks the activation
of MAPK and NF-jB DNA binding activity, as well as the expression
and secretion of pro-inﬂammatory cytokines such as TNF-a, IL-1b,
and IL-6 [11]. Consistent with a requirement for zinc in these path-
ways, recent studies indicate that addition of physiological concen-
trations of zinc enhances MAPK(s) activation and cytokine
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molecular targets affected by zinc remain poorly understood. To
better understand how zinc availability regulates immune cell sig-
naling, we investigated the effects of zinc deﬁciency and supple-
mentation on TLR4 signaling in the RAW264.7 macrophage cell
line as well as primary macrophages. Zinc depletion was found
to block the LPS-induced phosphorylation of several kinases
including IKK, MKK, and MAPKs. The phosphorylation and ubiqui-
tylation of the early kinase, IRAK1, was unperturbed by zinc deﬁ-
ciency, thus demonstrating a degree of selectivity in the signaling
events requiring zinc. However, the subsequent degradation of ubi-
quitylated IRAK1 occurred in a zinc-dependent manner that was
independent of the proteasome. These zinc dependent steps
involved in LPS signaling were conﬁrmed in mouse primary perito-
neal macrophages. Our ﬁndings identify discreet target proteins
whose participation in the TLR4 signaling pathway is dependent
on the availability of cytoplasmic zinc, thus providing new insights
into the molecular mechanisms by which zinc deﬁciency sup-
presses the innate immune system.2. Materials and methods
2.1. Animals and ethics
All animal husbandry and euthanasia procedures were per-
formed in accordance with and under the approval of the Animal
Care and Use Committee of the University of Missouri. Mice were
euthanized by isoﬂuorane anesthesia followed by cervical disloca-
tion. Mice were maintained on 12 h light–dark cycle and food and
water provided ad libitum.
2.2. Antibodies and reagents
Antibodies to phospho-ERK1/2 (T202/Y404), phospho-p38
(T180/Y182), phospho-IjB (S32), IjB, phospho-IKKa (S176)/IKKb
(S177), MKK6, phospho-MKK3/MKK6 (S189/207) were from Cell
Signaling Technologies (Danvers, MA). Antibodies to ERK1/2,
IRAK1, ubiquitin, IKKa/b were from Santa Cruz Biotechnology
(Santa Cruz, CA). Antibodies to beta tubulin, mouse IgG, and rabbit
IgG were from Sigma (St. Louis, MO). The antibody to actin was
from EMD Chemicals (Billerica, MA), lambda phosphatase was
from New England Biolabs (Ipswich, MA). MG132 and Epoxomicin
were from BIOMOL (Farmingdale, NY). Lipopolysaccharride,
N,N,N0,N0-Tetrakis (2-pyridylmethyl) ethylenediamine (TPEN),
were from Sigma. ZnCl2 was from Fisher Scientiﬁc (Pittsburgh, PA).
2.3. Cell culture
The mouse macrophage-like cell line RAW 264.7 was obtained
from the American Type Culture Collection and maintained in Dul-
becco’s modiﬁed Eagle’s medium containing 10% fetal bovine
serum, 100 lM non-essential amino acids, 2 mM L-glutamine and
100 units/mL penicillin and streptomycin in 5% CO2 at 37 C. Cells
were passaged at 1:8 dilution every 2 days.
Primary activated peritoneal macrophage cells isolated from
C57 BL/6 mice as described previously [19].
2.4. Cell treatments
For TPEN treatments, cells were incubated with 20 lM of TPEN
for 50 min. Subsequently, cells were treated with LPS with or with-
out the addition of zinc for 20 min before harvesting cells. For test-
ing for the role of the proteasome, RAW264.7 cells were pre-
treated with 20 lM of MG132 or 10 lM of epoxomicin for
50 min prior to treatment with LPS.2.5. Immunoblot analysis
After treatments, RAW 264.7 cells were washed twice with ice
cold 1X TBS (Tris-buffered saline) and collected with 2X Laemmli
buffer (20 mM sodium phosphate buffer pH 7.0, 0.01% Bromophe-
nol blue, 20% glycerol, 4% w/v SDS, add 40 mM DTT before use).
After sonication to shear DNA, lysates were heated at 95 C for
5 min and protein extracts (10 lg for p-ERK, p-p38, and ERK,
80 lg for p-IKKa/b, and 20 lg for other proteins) were separated
by 8% (ubiquitin), 10% (IKK a/b) or 11% (all other proteins) SDS–
PAGE gels, and transferred to PVDF membrane (Millipore) using
60 Volts for 2 h on ice. For proteins larger than 72 kD, 0.02% SDS
was added to transfer buffer, and the time for transfer was 3.5 h.
Membranes were incubated in blocking buffer (5% non-fat dry milk
in TBS/T) for 1 h at room temperature (RT). Membranes were
washed two times for 5 min each with 10 mL TBS/T and incubated
with primary antibody (dilutions of 1:250 for IRAK1, 1:500 for ubi-
quitin; and 1:1000 for all others) with gentle agitation overnight at
4 C. Membranes were washed four times for 5 min each with
10 mL of TBS/T before incubating with appropriate HRP-conjugated
secondary antibody (1:5000 for p-IKKa/b and 1:10,000 for other
proteins) in blocking buffer with gentle agitation for 1 h at RT.
Membranes were washed at least ﬁve times for 5 min each with
10 ml of TBS/T and then incubated with SuperSignal West Pico che-
miluminescence (Pierce) with or without the addition of 2–10%
Femto chemiluminescence (Pierce) for 3 min prior to exposure.
For stripping of blots, the membrane was incubated twice in strip-
ping buffer (25 mM glycine–HCl, pH 2, 1% SDS) for 10–15 min at RT
with shaking before washing with PBST for 5 min with shaking.
2.6. Phosphatase assays
After TPEN and LPS treatment, cells were washed twice with ice
cold 1 TBS and collected in 60 lL of appropriate lysis buffer. For
controls, Buffer 1 was used (100 mM HEPES-KOH pH7.5, 5% gly-
cerol, 0.1% SDS, 0.5% deoxychiolic acid, 1% NP-40, 1 mM PMSF,
10 mM leupeptin, 10 nM calyculin A, 5 mM NEM, 5 lg/mL apropti-
nin and 50 lMMG132). To inhibit phosphatases, Buffer 2 was used
(Buffer 1 with 15 mM EGTA, 5 mM EDTA, 5 mM NaPP, 1 mM NaMo,
50 mM NaF and 10 mM activated Na3VO4). For phosphatase treat-
ments, Buffer 3 was used (Buffer 1 with 8 mM of MnCl2 and 1 lL of
lambda phosphatase). For phosphatase treatments in the presence
of inhibitors, Buffer 4 was used (Buffer 2 with 8 mM of MnCl2 and
1 lL of phosphatase). Cell lysates were incubated at 37 C water for
20 min before terminating the reaction by adding 40 lL of
2.5  loading buffer and heating to 95 C for 5 min.
2.7. Immunoprecipitation
After treatments, cells were washed twice with ice-cold TBS and
resuspended in 900 lL cold lysis buffer (100 mM HEPES-KOH, pH
7.5, 0.5% sodium deoxycholate, 1% Nonidet P-40, 0.1% of SDS,
0.5 mM EDTA, 2 mM N-ethylmaleimide, 50 lM MG132, 1 mM
PMSF, 5 lg/mL aprotinin, 10 lM leupeptin, 50 mM NaPP, 25 mM
NaF, 150 mM NaCl, 1 nM calyculin A, 2.5 mM NEM). Cell lysates
were sonicated three times for 10 s on ice. Cell debris was removed
by centrifugation for 20 min at 16,000 g at 4 C. 30 lL of superna-
tant was saved as input. The remaining supernatant was pre-
cleared by incubating with 50 lL Protein G agarose beads with
rotation at 4 C for 2 h and then removing beads by centrifugation
at 16,000 g for 5 min. The supernatant was incubated with appro-
priate antibody overnight with rotation at 4 C prior to incubating
with 50 lL Protein G agarose beads for 1 h at 4 C with rotation.
Collected beads were washed three times with 500 lL of Low Salt
Buffer (25 mM Tris, pH 7.4, 5 mM EDTA, 100 mM NaCl, 0.1% Triton
X-100), three times with 500 lL of High Salt Buffer (25 mM Tris, pH
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water. Finally, beads were resuspended in 50 lL of 2 Leammeli
buffer and boiled at 95 C for 5 min prior to loading samples on
SDS–PAGE gels.
3. Results
3.1. Zinc enhances LPS-induced ERK activation in RAW264.7
macrophages
Recent studies demonstrated that activation of the TLR4 recep-
tor in primary monocytes and granulocytes resulted in a rapid rise
in free zinc levels in the cytoplasm [11]. In the mouse macrophage
cell line, RAW264.7, this rise in free zinc was shown to occur
within 2 min of LPS stimulation resulting in a 7–14-fold increase
in free zinc [11]. Zinc depletion was found to block MAPK activa-
tion and subsequent pro-inﬂammatory cytokine production [11].
While these studies provided clear evidence of a requirement for
zinc, the complement of molecular targets within the LPS signaling
pathway affected zinc deﬁciency remains poorly understood.
Our initial studies were aimed at deﬁning zinc-dependent steps
involved in LPS-signaling. First, we demonstrated a positive effect
of zinc by treating RAW264.7 cells for 20 min with a physiological
concentration of ZnCl2 (30 lM) together with increasing concen-
trations of LPS (5–50 ng/mL). The addition of zinc alone did not
induce the phosphorylation of ERK (Fig. 1A). However, the addition
of zinc increased ERK phosphorylation in response to LPS, particu-
larly at low LPS concentrations (Fig. 1A). Cells without zinc co-
treatment required approximately 10-fold more LPS to achieve
the same level of ERK phosphorylation as in cells treated with zinc
plus LPS, indicating that the presence of zinc potentiates LPS-
induced signaling responses in RAW264.7 cells.
To further demonstrate the requirement for zinc in LPS-induced
signaling, RAW264.7 cells were made zinc-deﬁcient by pretreat-
ment for 50 min with 20 lM of TPEN, a cell permeable zinc chela-
tor with a zinc/chelate ratio of 1:1 [20]. Consistent with previous
results [11], TPEN treatment was found to markedly inhibit phos-
phorylation of ERK in response to 50 ng/mL of LPS (Fig. 1B). This
effect of TPEN was due to zinc chelation since the addition of
30 lM Zn2+ prevented TPEN-mediated suppression of LPS-induced
activation of ERK (Fig. 1B). Moreover, this effect of TPEN was selec-
tive for zinc since the addition of other divalent metals (also addedFig. 1. Physiological concentrations of zinc synergistically amplify LPS-induced activatio
with increasing concentrations of LPS for 20 min. Immunoblot analysis was performed u
ERK protein as a loading control (ERK 1/2). (B) Cells were incubated with (+) or without (
or 30 lM zinc for 20 min. Immunoblot analysis was performed as described in (A). Exper
were treated as described for (B), but 30 lM of the divalent metal indicated (added as chlo
described in (A). Experiments were performed at least three times with similar resultsas chloride salts) could not prevent TPEN-induced block of LPS-
induced ERK phosphorylation (Fig. 1C).
3.2. Zinc is broadly required for TLR4 signaling protein
phosphorylation induced by LPS
The results above conﬁrmed the speciﬁc requirement for zinc
during LPS-induced MAPK phosphorylation. However, the extent
to which zinc is more broadly required for LPS signaling has not
been fully explored. Therefore, we investigated the requirements
for zinc in LPS-induced phosphorylation of a broad range of pro-
teins in the TLR4 pathway. TPEN treatment markedly suppressed
LPS-induced phosphorylation of MKK3/6 and p38, the kinases
which form part of the p38 pathway (Fig. 2A). We also tested the
effect of zinc depletion on signaling via IjB, a protein which inhi-
bits the NF-jB pathway by sequestering the NF-jB transcription
factor in the cytoplasm and preventing its access to the nucleus
[21]. In response to LPS stimulation, IjB is rapidly phosphorylated
and ubiquitylated, which targets this protein for proteasomal
degradation. LPS-induced IjB phosphorylation was inhibited by
TPEN treatment, but reapplication of zinc restored phosphorylation
(Fig. 2A). Similarly, the subsequent IjB degradation in response to
LPS was also blocked in TPEN-treated cells, but the addition of zinc
ameliorated these effects (Fig. 2A). We then focused on events
upstream of IjB which might be dependent on zinc availability.
The kinases, IKKa/b, required to phosphorylate IjB are also phos-
phorylated in response to LPS, and IKKa/b phosphorylation was
similarly dependent on zinc availability (Fig. 2A). Collectively,
these results demonstrate that zinc is required in multiple diver-
gent pathways downstream of LPS stimulation (summarized in
Fig. 2B, open circles).
3.3. Zinc is not required for IRAK1 phosphorylation
Because a broad spectrum of LPS-dependent phosphorylation
responses were dependent on zinc, we hypothesized that zinc is
required early in the TLR4 signaling pathway. One of the earliest
events in the activation of the TLR4 pathway is phosphorylation
of IRAK1, a kinase that forms part of a scaffold complex linked to
the TLR4 protein. Normally, LPS treatment results in phosphoryla-
tion, poly-ubiquitylation, and degradation of IRAK1 [22–29]. Con-
sistent with these previous studies, the levels of IRAK1 greatlyn of ERK. (A) RAW264.7 cells were treated with (+) or without () 30 lM zinc and
sing antibodies against the activated form of ERK (p-ERK 1/2) or against the native
) 20 lM TPEN for 50 min. Subsequently, cells were treated with 50 ng/mL LPS, and/
iments were performed at least three times with similar results as shown. (C) Cells
ride salts) was included with the treatment. Immunoblot analysis was performed as
as shown.
Fig. 2. Zinc is broadly required for LPS-induced phosphorylation of proteins in
signaling pathways. (A) Cells were treated as described in Fig. 1B. Immunoblot
analysis of protein extracts from treated cells were performed using antibodies
against activated (p-p38) p38 kinase, activated (p-MKK3/6) or native (MKK6) MAPK
kinases, phosphorylated (p-IjB) or native (IjB) IjB protein, or activated (p-IKKa/b)
or native (IKKa/b) IjB Kinase. Experiments were performed at least three times
with similar results as shown. (B) Model summarizing zinc-dependent (open circles
on protein) and zinc-independent (closed circles on protein) phosphorylation of
proteins involved in LPS-induced inﬂammatory signaling as described in this work.
Fig. 3. Zinc is not required for LPS-induced phosphorylation of IRAK1 but is
required for its degradation. (A) Cells were treated as described in Fig. 1B.
Immunoblot analysis of protein extracts from treated cells were performed using
antibodies against IRAK1 or actin proteins. Phosphorylated IRAK1 (IRAK1⁄) migrates
as an apparently higher MW form. (B) The apparently higher MW form is conﬁrmed
as phosphorylated IRAK1 (p-IRAK1) by phosphatase assay. Protein extracts were
treated in the presence (+) or absence () of phosphatase inhibitors or lambda (k)
phosphatase prior to immunoblot analysis as described in (A). Experiments were
performed at least three times with similar results as shown.
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The depletion of zinc using TPEN did not greatly affect the LPS-
induced decrease of native IRAK1. However, this treatment
resulted in the appearance of a slower migrating form of IRAK1(IRAK1⁄ in Fig. 3A, lane 4). The accumulation of this slower migrat-
ing form of IRAK1 was generated speciﬁcally in response to zinc
depletion as it was barely detectable in zinc replete cells that were
stimulated with LPS (Fig. 3A, lane 3) or when zinc was added to the
TPEN-treated LPS-stimulated cells (Fig. 3A, lane 5). In other cell
types IRAK1 is known to become hyperphosphorylated in response
to proinﬂammatory cytokines [22,24,25,27]. Therefore, we sus-
pected that the slower migrating species of IRAK1 in the zinc
depleted cells might represent the stabilization (or accumulation)
of a hyperphosphorylated form. This hypothesis was supported
by the ﬁnding that phosphatase treatment of protein lysates
resulted in the disappearance of the higher molecular weight spe-
cies of IRAK1, shifting it to the native form of IRAK (Fig. 3B, lane 3).
A control sample that included a phosphatase inhibitor during the
phosphatase treatment prevented this shift (Fig. 3B, lane 4). Taken
together, these data indicate that zinc depletion stabilizes the
accumulation of the phosphorylated form of IRAK1.
3.4. Zinc depletion does not block IRAK1 ubiquitylation
Previous studies have shown that IL-1/LPS stimulation of
HEK293 cells resulted in phosphorylation of IRAK1 and subsequent
K63-linked ubiquitylation and degradation [28]. Because IL-1R and
TLR4 share a common cytoplasmic motif (the Toll/IL-1R homology
domain) as well as MyD88 dependent signaling pathways [30], we
considered the possibility that zinc may be essential for IRAK1 ubi-
quitylation and/or degradation of IRAK1. This hypothesis would
account for (a) the disappearance of native IRAK1 in LPS-treated
cells and (b) the stabilization of the phosphorylated form owing
to the blockage of ubiquitylation and/or degradation by TPEN
treatment.
Consistent with this possibility, addition of TPEN during LPS sti-
mulation of cells resulted in the appearance of the high molecular
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in the presence of added zinc (Fig. 4A, lane 5). Because longer expo-
sures were required to visualize the higher molecular weight form
IRAK1 in these immunoblot experiments, the decrease in levels of
native IRAK1 in response to LPS alone was less obvious than in
Fig. 4 due to near saturation of the signal.
The most likely explanation for the appearance of this high MW
form is that IRAK1 becomes phosphorylated and poly-ubiquity-
lated after LPS treatment but that zinc is required for the degrada-
tion of IRAK1 once it is ubiquitylated. To address this possibility,
we directly assessed whether the high MW form of IRAK1 is, in
fact, ubiquitylated IRAK1. IRAK1 was immunoprecipitated from
LPS-stimulated, zinc-depleted cells; and the presence of ubiquitin
was determined by immunoblot analysis using anti-ubiquitin anti-
bodies. As shown in Fig. 4B, ubiquitylated protein was readily
detected in the higher MW species of immunoprecipitated IRAK1
in samples from zinc-deﬁcient cells in response to LPS-stimulation,
but not from untreated control cells (Fig. 4B, lanes 5 and 6). As a
control, no ubiquitin was detected in cell lysates immunoprecipi-
tated with equal amount of mouse IgG alone (i.e. no anti-IRAK1
antibody; Fig. 4B, lane 7–8). These results, together with those in
Fig. 3, demonstrate that IRAK1 is both phosphorylated and ubiqui-
tylated, and that these modiﬁed forms accumulate during zinc
depletion.
3.5. IRAK1 degradation is independent of the proteasome
As poly-ubiquitylation is often associated with proteasomal
degradation [31], we evaluated whether the zinc-dependent degra-
dation of poly-ubiquitylated IRAK1 was also proteasome-depen-
dent. RAW264.7 cells were pre-incubated with the proteasome
inhibitor, MG132, or TPEN, then incubated with LPS Surprisingly,
MG132 did not inhibit LPS-induced clearance of the native form
of IRAK nor did it induce the appearance of the higher molecular
weight forms in zinc replete cells (Fig. 5A, lane 7–9). The inability
of MG132 to block IRAK1 degradation was not due to a lack of
potency of the MG132 inhibitor because IjB degradation after
LPS treatment was blocked by MG132 in the same experiments
(Fig. 5A). Moreover, another proteasome inhibitor, epoxomycin,
which blocks a broader range of protease activities in the protea-
some [32] was found to inhibit LPS-induced degradation of IjB
but not the degradation of IRAK1 (Fig. 5B, lane 7–9). These resultsFig. 4. Zinc is not required for LPS-induced ubiquitylation of IRAK1. (A) Cells were treated
except that images were exposed for longer to visualize the higher MW form of IRAK1 (IR
50 ng/mL LPS (TL) for 20 min or not treated (). Lanes show samples from either total p
control. Immunoblot (IB) analyses were performed using either anti-ubiquitin (Ub) or a
IRAK1 antibodies is indicated as ubiquitylated IRAK1 (Ub-IRAK1). Experiments were perindicate that although zinc is required for the degradation of poly-
ubiquitylated IRAK1, this process is independent of the
proteasome.3.6. IRAK1 is degraded in a zinc dosage dependent manner
To further investigate the possible relation between the zinc
requirement for IRAK1 degradation and the downstream effects
on phosphorylation, we examined the minimal concentration of
zinc required to reverse the stabilization of ubiquitylated IRAK1
by TPEN. The form of Ub-IRAK1 stabilized by 20 lM TPEN in LPS
treated cells required between 20 and 30 lM zinc (Fig. 6A). Consid-
ering that TPEN chelates zinc at equimolar amounts [20], these
ﬁndings are consistent with low levels of zinc in the physiological
range required to elicit IRAK1 degradation. Interestingly, there was
a strong correlation between the concentrations of zinc required to
restore the degradation of IRAK1 and the restoration of phosphor-
ylation of the downstream ERK, indicating that the stabilization of
IRAK1 may be responsible for the inhibition of downstream signal-
ing events. Furthermore, the addition of zinc (30 lM) potentiated
LPS induced IRAK degradation similar to the additive effect found
for ERK activation (Fig. 6B). These results further support our ﬁnd-
ings that the degradation of IRAK1 during early LPS responses is a
novel site of action for zinc in TLR4 signaling.3.7. Zinc is required for LPS signaling via IRAK1 in primary peritoneal
macrophages
To verify whether our in vitro observations in RAW264.7 cells
occur in primary macrophages, we assessed these responses in
peritoneal macrophages isolated from mice. Consistent with the
results using RAW264.7 cells, the LPS-induced phosphorylation of
ERK1/2, p38, MKK3/6, IjB, and IKKs was inhibited by TPEN and
restored by zinc supplementation in the cultured primary macro-
phages (Fig. 7). Moreover, zinc depletion of the primary macro-
phages using TPEN was found to stabilize both the
phosphorylated and ubiquitylated forms of IRAK1 (Fig. 7). Taken
together, these results from in vitro and ex vivo macrophage cul-
tures demonstrate a requirement for zinc in LPS-induced IRAK
degradation and subsequent downstream phosphorylation
cascades.as described in Fig. 1B. Immunoblot analysis was performed as described in Fig. 3A
AK1⁄⁄). (B) Cells were incubated for with 20 lM TPEN 50 min, and then treated with
rotein input (Input) or after immunoprecipitation (IP) with either IRAK1 or IgG as a
nti-IRAK1 (IRAK1) antibodies. The high MW form cross-reacting with both Ub and
formed at least three times with similar results as shown.
Fig. 5. LPS-induced degradation of IRAK1 does not require proteasome activity.
Cells were incubated with (+) or without () 20 lM TPEN, or the proteasome
inhibitors (A) 20 lM MG132 or (B) 10 lM epoxymcyin for 50 min. Then cells were
treated with 50 ng/mL LPS for indicated time. Immunoblot analyses revealed the
presence or absence of unmodiﬁed IRAK1, phosphorylated IRAK1 (p-IRAK1), or
ubiquitylated IRAK1 (Ub-IRAK1). As a control for the effectiveness of proteasome
inhibition, immunoblot analysis of IjB, which is degraded via the proteasome
following LPS treatment, was used. Immunoblot analysis of tubulin was used as a
loading control. Experiments were performed at least three times with similar
results as shown.
Fig. 6. LPS-induced degradation of IRAK1 is dependent on the concentration of zinc.
(A) Cells were treated as described in Fig. 1B except with multiple different
concentrations of zinc. (B) Cells were treated as described in Fig. 1A. Immunoblot
was performed to detect the forms of IRAK1 described in Fig. 4, activated ERK (p-
ERK 1/2) as described in Fig. 1, and tubulin as a loading control.
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To investigate potential roles for zinc in TLR4 signaling, 30 lM
zinc chloride was used in these studies without the use of any zinc
ionophores [33], which approximately mimics the physiological
concentration of zinc in blood plasma [34,35]. This low-dose zinc
treatment avoids potential complications of extended effects from
high zinc concentrations [36–39].
Although zinc has previously been demonstrated to be required
for proper TLR4 signaling [11,13], a potential site of action for zinc
has not been elucidated. Our ﬁnding that zinc deﬁciency affected a
broad range of protein phosphorylation in disparate pathways
downstream of TLR4 (ERK1/2 MKK3/6, IKKb, and IjB) suggested
that zinc is required during early TLR4 signaling events. A require-
ment for zinc in LPS binding to the TLR4 receptor itself was ruled
out because zinc depletion did not block phosphorylation andubiquitylation of IRAK1. However, zinc depletion blocked IRAK1
degradation, resulting in the accumulation of phosphorylated and
ubiquitylated forms of this protein.
IRAK1 is part of a membrane-associated protein complex that
contains the regulatory kinases IKKa and IKKb which become
phosphorylated in response to LPS [28,29,40] (Fig. 2B). The ensuing
phosphorylation and degradation of IRAK1 triggers the release of
these p-IKKs to cytoplasm, which permits p-IKK-mediated phos-
phorylation and degradation of IjB and p105 [21]. The removal
of IjB allows nuclear access of the NF-kB transcription factor,
whereas the degradation of p105 releases active Tpl2, a MEK
kinase, leading to the phosphorylation of ERK1/2 [21,41–43]. Thus,
our ﬁnding that zinc depletion prevented IRAK1 degradation,
resulting in the accumulation of the phosphorylated/ubiquitylated
forms, provides a possible explanation for the inhibition of multi-
ple pathways stemming from IRAK1.
Although our data clearly demonstrate a novel role for zinc in
the degradation of IRAK1, it is important to note that zinc could
have multiple sites of action in TLR4 signaling. For instance, many
studies have described the ability of zinc to inhibit at least some
protein tyrosine phosphatase activities, presumably by competing
with the metal cofactors required for proper enzyme activity [44–
47]. The general inhibition of phosphatase activity may promote
the increase in protein phosphorylation upon activation of the
upstream kinase(s); and in many immune signaling pathways,
including the TLR4 pathway, zinc has been found to prolong tyro-
sine protein phosphorylation, probably due to the suppression of
some phosphatases activity [10,11]. For instance, zinc has been
shown to inhibit protein tyrosine phosphatase 1B (PTP1B) [47];
and PTP-1B can directly dephosphorylate the phosphor-tyrosine
residue of activated MAPKs such as p38 in its activation loop [48].
Therefore, some or all of the phosphorylation events downstream
Fig. 7. Requirement for zinc in LPS-induced signaling events is also observed in
primary mouse peritoneal macrophage cells. Primary mouse peritoneal macro-
phage cells were treated as described in Fig. 1B. Immunoblot analyses were
performed as described for the RAW264.7 cells in Figs. 1, 2 and 4.
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tase inhibition.
Our results clearly indicate that at the initial stage, the stabiliza-
tion of modiﬁed IRAK1 forms during zinc deﬁciency occurred inde-
pendently of the proteasome. Proteasome-dependent degradation
typically targets Lys48-linked ubiquitylated proteins, such as IjB
in response to LPS [43]. However, unlike IjB, IRAK1 has been
reported to be Lys63-linked ubiquitylated, a modiﬁcation essential
in signal transduction but not classically associated with degrada-
tion [28,49–51]. Although the mechanisms of ubiquitylated IRAK1
degradation are poorly understood, our proteasome-independent
model at the early stage of stimulation is consistent with numer-
ous studies. For instance, using polyubiquitin linkage-speciﬁc anti-
bodies, Newton et al. proposed that, IRAK1 is initially K63-linked
polyubiquitylated upon IL-1b treatment; but after an hour of treat-
ment, IRAK1 becomes Lys48-linked ubiquitylated [52]. Accord-
ingly, in the ﬁrst hour of stimulation, treatment with the
proteasome inhibitor MG132 did not inhibit the degradation of
native IRAK1 nor result in the accumulate of ub-IRAK1. Similarly,
others also reported that inhibition of the proteasome was unable
to inhibit IRAK1 degradation upon IL-1b treatment in IL-1R cells
[29] or in 293 cells [24] in the ﬁrst 30 min. Reports of protea-
some-dependent IRAK1 degradation usually involve longer treat-
ment times (1–4 h) [24,52,53]. Therefore, our results are
consistent with a model where IRAK1 degradation occurs by two
separate mechanisms, a proteasome-independent event in the ﬁrst
hour of response and a proteasome-dependent mechanism at later
time points. Moreover, our results indicate the early response
involves a previously unidentiﬁed zinc-dependent mechanism.What might be the mechanism by which zinc depletion pre-
vents degradation of ubiquitylated/phosphorylated IRAK1 during
these early time points? The most likely possibility is that zinc
deﬁciency prevents the activity of zinc-containing metallopro-
teases that might be required for IRAK1 degradation independently
of the proteasome. It is also possible, however, that zinc may func-
tion at multiple steps in TLR4 signaling. For instance, zinc deﬁ-
ciency may limit the function of NEMO and TAB2, which are
components of the TLR4 signaling complex that have zinc-contain-
ing ubiquitin binding domains (UBDs) essential for TLR4 signal
transduction. As NEMO serves as a scaffolding protein to recruit
the IKKs for phosphorylation [49,54,55], the failure of NEMO to
bind through its UBD may prevent the proper recruitment of IKKb
for phosphorylation. Similarly, the zinc ﬁnger domain of TAB2 is
critical for the recruitment of TAK1 for activation and subsequent
IKKb activation [56].
In summary, our ﬁndings identify a key step in TLR4 signaling
that is sensitive to zinc deﬁciency; and in so doing, we have pro-
vided possible new directions for identifying proteasome-indepen-
dent pathways for targeted protein degradation.
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